How They Filmed a Bugatti Chiron at 250 MPH: All Details and the Camera Car Revealed : Automotive Addicts

bugatti chiron 250 mph filming

The film car wasn’t a Toyota Supra.

Remember the time Bugatti set out to film their new Chiron for a world record run from 0 to 400kph (250mph) and then back to zero? Well, many people, at the time of the video release, correctly guessed what the camera car was to keep up with the Bugatti Chiron at 250 mph. To reach such a speed, as no surprise to us “logical” thinkers, the crew used another Bugatti Chiron as the camera car, of course.

While use of another Chiron as the camera car is a nice surprise to some, the surprises keep rolling after finding out that the footage filmed was so smooth that they purposely added shake to the picture because, you know, TECHNOLOGY! Yes, the camera and equipment, including the remarkably-engineered Bugatti Chiron, was ultra-smooth, “almost lifeless” as explained by the film crew.

The camera installed on the Chiron happened to be a DJI X5, which was mounted in an area hit with hot exhaust gasses along with air passed through the vehicle used to cool some of the many radiators, oil coolers, and turbo coolers equipped on the Bugatti Chiron. Talking about some HOT footage – literally.

The video below dives in deep to show you all of the intricacies of how they filmed a Bugatti Chiron at 250 mph. Enjoy!

Fitbit adds GPS and Spotify control for the Charge 4 – TechCrunch

Fitbit adds GPS and Spotify control for the Charge 4 – TechCrunch

Let’s be real: Now isn’t the ideal time to launch a health tracker. For a majority of us, expectations have dramatically plummeted for step counts, workout minutes and other gamified metrics. But hardware launches will, for the most part, go on.

Fitbit eschewed its normal press event this time out — for increasingly good reason — instead opting to launch the Charge 4 by way of press release. The line is modest, in a wearable category that’s begun to be dominated by smartwatches, but it’s a cornerstone product that continues to do well for the soon-to-be Google-owned hardware company.

The biggest news here is built-in GPS — a big addition for the category — and Spotify control. The Spotify bit uses “Connect & Control,” requiring a premium account to play back music from playlists.

Better news for those stuck at home are a number of yoga and other workouts directly accessible through a Fitbit Premium account. That’s available as a 90-day trial for new users. Other news: on-board software updates include Active Zone Minutes, which provides more detailed workout requirements informed by the WHO and AMA, along with improved sleep measurements.

Lifestyle photo of Fitbit Charge 4

GPS is a nice addition, but nothing particularly groundbreaking here. At the very least, the update will pump a little fresh blood into what’s become a flagging category, as smartwatches (Fitbit’s included) have begun to increasingly suck the air out of the room for other wearables.

The Charge 4 will hit stores “in

2020 Mercedes-AMG GLC 43 Review & Test Drive : Automotive Addicts

2020 mercedes-amg glc 43

There’s no doubt that the Mercedes-Benz palette is vast, offering up just about every type of vehicle you can imagine except a pick-up truck here in the USA. With such, slotted in the middle of all of the models, is the latest GLC compact luxury crossover. The GLC has many flavors, and this week I have the chance to explore the Mercedes-AMG GLC 43, which falls just below the GLC 63 that I experienced a few months ago.

>> Get the best price on the Mercedes-Benz GLC from a network of local dealers now. <<

The 2020 GLC 43 is an AMG vehicle despite it not having the thrashing power of the brand’s hand-built BiTurbo V8. Instead, the GLC 43 makes do with a respected powertrain, a BiTurbo V6 good for 385 horsepower and 384 lb-ft of torque sent through a 9-speed automatic transmission before it gets directed to all four wheels.

2020 mercedes-amg glc 43 side profile

Performance in the compact luxury crossover is well below the level of the GLC 63, which has an 84 horsepower and a 95 lb-ft of torque advantage, combined with what feels like a more sure-footed handling ability – possibly due to having more mass to move around. While either of the crossovers are not sports cars, they attempt to play a nice game of hiding their weight and higher center of gravity through the remarkable dynamics that Mercedes-AMG has instilled in their adaptive suspension systems. The setup nicely balances comfort and sport, with a dial-in to either

Cell and gene therapy startup ElevateBio raises $170M – TechCrunch

Cell and gene therapy startup ElevateBio raises $170M – TechCrunch

While economic conditions and the ongoing global coronavirus pandemic may not make for the best atmosphere for raising funding, some companies are still announcing round closures with significant money committed. Cambridge-based ElevateBio, for instance, revealed a $170 million Series B funding on Monday, with participation from new investors The Invus Group, Surveyor Capital, EDBI, and Vertex Ventures, along with existing investors F2 Ventures, MPM Capital, EcoR1 Capital, Redmile Group and Samsara BioCapital.

ElevateBio, which was officially launched to the public less than a year ago, specializes in development of new types of cellular and genetic therapies, and operates by the creation of new companies under its portfolio each dedicated to the development and manufacturing of a specific type of therapeutic approach. This funding brings the total raised by ElevateBio to over $300 million, on top of a $150 million Series A round that the company announced last year, led by Swiss investment bank UBS’ Oncology Impact Fund.

The biotech company has ramped up quickly, nearing completion of a 140,000 square foot facilitating in Massachusetts to focus on R&D. It also launched a company called AlloVir that’s working on T-cell immunotherapy for combating viruses that specifically arise stem cell transplantations and is already in the later stages of clinical trials. Finally, it launched another company called HighPassBio, which is also aimed at helping treat stem cell-related diseases using T-cell therapies, in this case specifically around the potential relapse of leukaemia following a transplant.

As you might expect, ElevateBio is also

Now might be the perfect time to rethink your fundraising approach – TechCrunch

Now might be the perfect time to rethink your fundraising approach – TechCrunch

Many founders will have kicked off the new year with a new fundraising round. According to the data we shared last year, March, October and November were the months when VCs were reviewing the most decks.

But the COVID-19 pandemic has ground to a halt many industries, and there are even warnings that this will affect the next two quarters in regards to fundraising.

We’ve reviewed the data in our 2020 DocSend Startup Index and we’ve begun tracking the Pitch Deck Interest Metric. With San Francisco under a shelter-in-place order and many VCs scrambling to adjust their processes to an all-remote world, we saw pitch deck interest drop 11.6% when compared to the same week in 2019. While there has been a drop in interest so far, there is still a lot of activity, and VCs seem to still be reading pitch decks.

We will be monitoring the Pitch Deck Interest Metric in the coming weeks, but if you’re an early-stage startup and are in the middle of your fundraise, or are about to fundraise, there are some things you can